Items where Author is "Pfister, M."
Jump to: 2022 Number of items: 4. 2022Smit, C. and Hofmann, D. and Sayasone, S. and Keiser, J. and Pfister, M.. (2022) Characterization of the population pharmacokinetics of moxidectin in adults infected with strongyloides stercoralis: support for a fixed-dose treatment regimen. Clinical pharmacokinetics, 61. pp. 123-132. Hofmann, D. and Smit, C. and Sayasone, S. and Pfister, M. and Keiser, J.. (2022) Optimizing moxidectin dosing for Strongyloides stercoralis infections: insights from pharmacometric modeling. Clin Transl Sci, 15 (3). pp. 700-708. Hofmann, D. and Brussee, J. M. and Schulz, J. D. and Coulibaly, J. T. and Pfister, M. and Keiser, J.. (2022) Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adults. J Antimicrob Chemother, 77 (4). pp. 1082-1093. Smit, C. and Sen, S. and von Dach, E. and Karmime, A. and Lescuyer, P. and Tonoli, D. and Bielicki, J. and Huttner, A. and Pfister, M.. (2022) Steering away from current amoxicillin dose reductions in hospitalized patients with impaired kidney function to avoid subtherapeutic drug exposure. Antibiotics (Basel), 11 (9). p. 1190. |
